Cheng, M. L., Lau, C. J., Milan, M. S. D., Supplee, J. G., Riess, J. W., Bradbury, P. A., . . . Paweletz, C. P. (2021). Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC. JCO Precis Oncol.
Chicago-tyylinen lähdeviittausCheng, Michael L., Christie J. Lau, Marina S. D. Milan, Julianna G. Supplee, Jonathan W. Riess, Penelope A. Bradbury, Pasi A. Jänne, Geoffrey R. Oxnard, ja Cloud P. Paweletz. "Plasma CtDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC." JCO Precis Oncol 2021.
MLA-viiteCheng, Michael L., et al. "Plasma CtDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC." JCO Precis Oncol 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.